AlloVir (NASDAQ:ALVR) stock is falling hard on Thursday after the company announced the pricing of a public share offering. That offering has AlloVir selling 20 million shares of ALVR stock for $3.75 ...
SVB Securities analyst Mani Foroohar reiterated a Buy rating on AlloVir (ALVR - Research Report) on November 3 and set a price target of $24.00. The companys shares closed last Friday at $7.09.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback